Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rebeccatech is a private medtech company developing medical devices based on biocompatible micro-electromechanical systems and micro-radiofrequency technology. The company operates across the U.S. and China and focuses on minimally invasive or non-invasive device applications in urology, dermatology, and related specialty care settings. Its best-described lead product area is microRF treatment for overactive bladder, alongside commercial aesthetic dermatology devices such as Nebulyft. Rebeccatech positions itself as a platform company built around non-silicon biocompatible MEMS manufacturing and precision energy delivery for medical devices. The company appears to be active, venture-backed, and commercially selling at least some dermatology products while continuing broader device development and clinical deployment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rebeccatech.